Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Artificial Intelligence-based Parkinson's Disease Risk Assessment (AI-PRA) Study

NCT: NCT07706829 · NOT_YET_RECRUITING

NCT IDNCT07706829
StatusNOT_YET_RECRUITING
Start Date2026-07-01
Completion2027-09-30
SponsorQueen Mary University of London (OTHER)
First posted
Last updated

Brief Summary

The study aims to provide initial proof-of-concept validation data of an artificial intelligence-based model to estimate individual Parkinson's disease risk using demographic, clinical, genetic information and digital biomarker data collected via a smartwatch and a mobile application.

Frequently Asked Questions

What is Artificial Intelligence-based Parkinson's Disease Risk Assessment (AI-PRA) Study?

Artificial Intelligence-based Parkinson's Disease Risk Assessment (AI-PRA) Study is a clinical trial registered under NCT07706829. Current status: NOT_YET_RECRUITING.

What is the status of NCT07706829?

The current status of NCT07706829 (Artificial Intelligence-based Parkinson's Disease Risk Assessment (AI-PRA) Study) is: NOT_YET_RECRUITING.

When did Artificial Intelligence-based Parkinson's Disease Risk Assessment (AI-PRA) Study start?

Artificial Intelligence-based Parkinson's Disease Risk Assessment (AI-PRA) Study started on 2026-07-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑